← Back to headlines
Pliant Therapeutics Reports Q4 Earnings
Pliant Therapeutics announced its GAAP EPS for the fourth quarter was -$0.38, which was in line with analyst expectations.
11 Mar, 20:36 — 11 Mar, 20:36
Sources
Showing 1 of 1 sources
Pliant Therapeutics announced its GAAP EPS for the fourth quarter was -$0.38, which was in line with analyst expectations.
